A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3256-3257
10.1182/blood-2022-167765